Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ocular surface lubricants, commonly known as artificial tears or tear substitutes, are therapeutic agents designed to supplement or replace the natural tear film in patients with ocular surface diseases (PubMed, 2008). They function by providing hydration, reducing friction between the eyelid and the cornea, and stabilizing the tear film's lipid, aqueous, and mucin layers (Oxford Academic, 2024). These agents typically consist of viscosity-enhancing polymers such as carboxymethylcellulose or sodium hyaluronate, which mimic the viscoelastic properties of natural tears and increase the retention time on the eye (eOphtha, 2022). In addition to physical lubrication, some modern formulations act as osmoprotectants, shielding the corneal epithelium from the hyperosmotic stress that characterizes dry eye syndrome (Midlands Medicines, 2013). While primarily used for symptomatic relief, specialized lubricants like recombinant human lubricin are also utilized to promote the healing of the ocular surface and restore the integrity of the glycocalyx-mucin interface (Current Ophthalmology Reports, 2025). They remain the cornerstone of first-line therapy for maintaining ocular comfort and visual clarity in conditions like keratoconjunctivitis sicca (SciELO, 2016).
Physical supplementation of the tear film layers to provide hydration, increase viscosity, and reduce mechanical friction on the ocular surface (PubMed, 2008; Oxford Academic, 2024).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ocular surface lubricant.